NB100-56559
antibody from Novus Biologicals
Targeting: S100A7
PSOR1, S100A7c
Antibody data
- Antibody Data
- Antigen structure
- References [51]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [6]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-56559 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-56559, RRID:AB_838744
- Product name
- Mouse Monoclonal S100A7/Psoriasin Antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Sustained Secretion of the Antimicrobial Peptide S100A7 Is Dependent on the Downregulation of Caspase-8.
Pseudomonas aeruginosa flagellum is critical for invasion, cutaneous persistence and induction of inflammatory response of skin epidermis.
Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ.
A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model.
IL-17F regulates psoriasis-associated genes through IκBζ.
S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.
Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects.
Foreskin-isolated keratinocytes provide successful extemporaneous autologous paediatric skin grafts.
Radiotherapy for oral cancer decreases the cutaneous expression of host defence peptides.
Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.
Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7.
Study of proliferation and 3D epidermal reconstruction from foreskin, auricular and trunk keratinocytes in children.
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M.
The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulators.
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.
Expression of S100 protein family members in normal skin and sweat gland tumors.
Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.
Quantitative comparison of the expression of antimicrobial peptides in the oral mucosa and extraoral skin.
Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus.
S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.
Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis.
Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha.
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer.
Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features.
Biological Markers Predictive of Invasive Recurrence in DCIS.
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation.
Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes.
Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes.
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.
Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation.
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes.
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes.
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection.
A putative role for psoriasin in breast tumor progression.
Molecular markers in ductal carcinoma in situ of the breast.
Psoriasin expression in mammary epithelial cells in vitro and in vivo.
Bhatt T, Bhosale A, Bajantri B, Mathapathi MS, Rizvi A, Scita G, Majumdar A, Jamora C
Cell reports 2019 Nov 26;29(9):2546-2555.e4
Cell reports 2019 Nov 26;29(9):2546-2555.e4
Pseudomonas aeruginosa flagellum is critical for invasion, cutaneous persistence and induction of inflammatory response of skin epidermis.
Garcia M, Morello E, Garnier J, Barrault C, Garnier M, Burucoa C, Lecron JC, Si-Tahar M, Bernard FX, Bodet C
Virulence 2018;9(1):1163-1175
Virulence 2018;9(1):1163-1175
Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
Li L, Cui Y, Ye L, Zhao Z, Jiang WG, Ji J
International journal of oncology 2018 Sep;53(3):1171-1182
International journal of oncology 2018 Sep;53(3):1171-1182
The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ.
Bertelsen T, Iversen L, Johansen C
Experimental dermatology 2018 Sep;27(9):1048-1052
Experimental dermatology 2018 Sep;27(9):1048-1052
A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model.
Rosignoli C, Thibaut de Ménonville S, Orfila D, Béal M, Bertino B, Aubert J, Mercenier A, Piwnica D
Experimental dermatology 2018 Apr;27(4):358-365
Experimental dermatology 2018 Apr;27(4):358-365
IL-17F regulates psoriasis-associated genes through IκBζ.
Bertelsen T, Ljungberg C, Boye Kjellerup R, Iversen L, Johansen C
Experimental dermatology 2017 Mar;26(3):234-241
Experimental dermatology 2017 Mar;26(3):234-241
S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.
Tian T, Li X, Hua Z, Ma J, Wu X, Liu Z, Chen H, Cui Z
Oncotarget 2017 Apr 11;8(15):24964-24977
Oncotarget 2017 Apr 11;8(15):24964-24977
Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects.
Bianco K, Gormley M, Farrell J, Zhou Y, Oliverio O, Tilden H, McMaster M, Fisher SJ
Prenatal diagnosis 2016 Sep;36(9):812-22
Prenatal diagnosis 2016 Sep;36(9):812-22
Foreskin-isolated keratinocytes provide successful extemporaneous autologous paediatric skin grafts.
Mcheik JN, Barrault C, Pedretti N, Garnier J, Juchaux F, Levard G, Morel F, Lecron JC, Bernard FX
Journal of tissue engineering and regenerative medicine 2016 Mar;10(3):252-60
Journal of tissue engineering and regenerative medicine 2016 Mar;10(3):252-60
Radiotherapy for oral cancer decreases the cutaneous expression of host defence peptides.
Koerdt S, Steinstraesser L, Stoeckelhuber M, Wales CJ, Rohleder NH, Babaryka G, Steiner T, Wolff KD, Loeffelbein DJ, Muecke T, Nieberler M, Kesting MR
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2016 Jul;44(7):882-9
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2016 Jul;44(7):882-9
Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.
Dey KK, Sarkar S, Pal I, Das S, Dey G, Bharti R, Banik P, Roy J, Maity S, Kulavi I, Mandal M
Cancer cell international 2015;15:74
Cancer cell international 2015;15:74
Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7.
Chu YW, Liu ST, Cheng HC, Huang SM, Chang YL, Chiang CP, Liu YC, Wang WM
PloS one 2015;10(12):e0144175
PloS one 2015;10(12):e0144175
Study of proliferation and 3D epidermal reconstruction from foreskin, auricular and trunk keratinocytes in children.
Mcheik JN, Barrault C, Pedretti N, Garnier J, Juchaux F, Levard G, Morel F, Bernard FX, Lecron JC
Burns : journal of the International Society for Burn Injuries 2015 Mar;41(2):352-8
Burns : journal of the International Society for Burn Injuries 2015 Mar;41(2):352-8
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, Nasser MW, Ganju RK
Molecular cancer 2015 Jan 27;14:11
Molecular cancer 2015 Jan 27;14:11
Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M.
Rabeony H, Petit-Paris I, Garnier J, Barrault C, Pedretti N, Guilloteau K, Jegou JF, Guillet G, Huguier V, Lecron JC, Bernard FX, Morel F
PloS one 2014;9(7):e101937
PloS one 2014;9(7):e101937
The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulators.
de Castro A, Minty F, Hattinger E, Wolf R, Parkinson EK
Longevity & healthspan 2014;3:8
Longevity & healthspan 2014;3:8
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
Teng X, Hu Z, Wei X, Wang Z, Guan T, Liu N, Liu X, Ye N, Deng G, Luo C, Huang N, Sun C, Xu M, Zhou X, Deng H, Edwards CK 3rd, Chen X, Wang X, Cui K, Wei Y, Li J
Journal of immunology (Baltimore, Md. : 1950) 2014 Feb 15;192(4):1815-23
Journal of immunology (Baltimore, Md. : 1950) 2014 Feb 15;192(4):1815-23
Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.
Ye L, Sun PH, Martin TA, Sanders AJ, Mason MD, Jiang WG
Urologic oncology 2013 Nov;31(8):1576-83
Urologic oncology 2013 Nov;31(8):1576-83
Expression of S100 protein family members in normal skin and sweat gland tumors.
Zhu L, Okano S, Takahara M, Chiba T, Tu Y, Oda Y, Furue M
Journal of dermatological science 2013 Jun;70(3):211-9
Journal of dermatological science 2013 Jun;70(3):211-9
Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
Sneh A, Deol YS, Ganju A, Shilo K, Rosol TJ, Nasser MW, Ganju RK
Breast cancer research and treatment 2013 Apr;138(3):727-39
Breast cancer research and treatment 2013 Apr;138(3):727-39
The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.
Vegfors J, Petersson S, Kovács A, Polyak K, Enerbäck C
PloS one 2012;7(12):e53119
PloS one 2012;7(12):e53119
Quantitative comparison of the expression of antimicrobial peptides in the oral mucosa and extraoral skin.
Kesting MR, Mueller C, Wagenpfeil S, Stoeckelhuber M, Steiner T, Bauer F, Teichmann J, Baumann CM, Barthel LC, Satanovskij RM, Mücke T, Schulte M, Schütz K, Wolff KD, Rohleder NH
The British journal of oral & maxillofacial surgery 2012 Jul;50(5):447-53
The British journal of oral & maxillofacial surgery 2012 Jul;50(5):447-53
Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
Shubbar E, Vegfors J, Carlström M, Petersson S, Enerbäck C
Breast cancer research and treatment 2012 Jul;134(1):71-80
Breast cancer research and treatment 2012 Jul;134(1):71-80
Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus.
Garreis F, Gottschalt M, Schlorf T, Gläser R, Harder J, Worlitzsch D, Paulsen FP
Investigative ophthalmology & visual science 2011 Jul 1;52(7):4914-22
Investigative ophthalmology & visual science 2011 Jul 1;52(7):4914-22
S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.
Andresen E, Lange C, Strodthoff D, Goldmann T, Fischer N, Sahly H, Branscheid D, Heine H
BMC pulmonary medicine 2011 Feb 15;11:10
BMC pulmonary medicine 2011 Feb 15;11:10
Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis.
Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, Guillet G, Bernard FX, Lecron JC, Morel F
Journal of immunology (Baltimore, Md. : 1950) 2010 May 1;184(9):5263-5270
Journal of immunology (Baltimore, Md. : 1950) 2010 May 1;184(9):5263-5270
Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha.
Hashiramoto A, Yamane T, Tsumiyama K, Yoshida K, Komai K, Yamada H, Yamazaki F, Doi M, Okamura H, Shiozawa S
Journal of immunology (Baltimore, Md. : 1950) 2010 Feb 1;184(3):1560-5
Journal of immunology (Baltimore, Md. : 1950) 2010 Feb 1;184(3):1560-5
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer.
Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P, Gunsior M, Vonderhaar BK, Olson M, Watson PH, Yuspa SH
Cancer letters 2009 May 8;277(1):101-7
Cancer letters 2009 May 8;277(1):101-7
Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features.
Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, Wagenpfeil S, Al-Benna S, Jacobsen F, Steinstraesser L
Oral oncology 2009 Aug;45(8):731-6
Oral oncology 2009 Aug;45(8):731-6
Biological Markers Predictive of Invasive Recurrence in DCIS.
Nofech-Mozes S, Spayne J, Rakovitch E, Kahn HJ, Seth A, Pignol JP, Lickley L, Paszat L, Hanna W
Clinical medicine. Oncology 2008;2:7-18
Clinical medicine. Oncology 2008;2:7-18
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation.
Paruchuri V, Prasad A, McHugh K, Bhat HK, Polyak K, Ganju RK
PloS one 2008 Mar 5;3(3):e1741
PloS one 2008 Mar 5;3(3):e1741
Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes.
Pène J, Chevalier S, Preisser L, Vénéreau E, Guilleux MH, Ghannam S, Molès JP, Danger Y, Ravon E, Lesaux S, Yssel H, Gascan H
Journal of immunology (Baltimore, Md. : 1950) 2008 Jun 1;180(11):7423-30
Journal of immunology (Baltimore, Md. : 1950) 2008 Jun 1;180(11):7423-30
Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes.
Pène J, Chevalier S, Preisser L, Vénéreau E, Guilleux MH, Ghannam S, Molès JP, Danger Y, Ravon E, Lesaux S, Yssel H, Gascan H
Journal of immunology (Baltimore, Md. : 1950) 2008 Jun 1;180(11):7423-30
Journal of immunology (Baltimore, Md. : 1950) 2008 Jun 1;180(11):7423-30
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, Chavakis T, Oppenheim JJ, Yuspa SH
Journal of immunology (Baltimore, Md. : 1950) 2008 Jul 15;181(2):1499-506
Journal of immunology (Baltimore, Md. : 1950) 2008 Jul 15;181(2):1499-506
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, Chavakis T, Oppenheim JJ, Yuspa SH
Journal of immunology (Baltimore, Md. : 1950) 2008 Jul 15;181(2):1499-506
Journal of immunology (Baltimore, Md. : 1950) 2008 Jul 15;181(2):1499-506
Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, Mao Y, Li M, Peng A, He D, Xiao X
Thorax 2008 Apr;63(4):352-9
Thorax 2008 Apr;63(4):352-9
S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
Petersson S, Bylander A, Yhr M, Enerbäck C
BMC cancer 2007 Nov 6;7:205
BMC cancer 2007 Nov 6;7:205
Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
Zhang H, Wang Y, Chen Y, Sun S, Li N, Lv D, Liu C, Huang L, He D, Xiao X
Lung cancer (Amsterdam, Netherlands) 2007 Jul;57(1):37-45
Lung cancer (Amsterdam, Netherlands) 2007 Jul;57(1):37-45
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, Kasman I, Winer J, Modrusan Z, Danilenko DM, Ouyang W
Journal of immunology (Baltimore, Md. : 1950) 2007 Feb 15;178(4):2229-40
Journal of immunology (Baltimore, Md. : 1950) 2007 Feb 15;178(4):2229-40
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, Kasman I, Winer J, Modrusan Z, Danilenko DM, Ouyang W
Journal of immunology (Baltimore, Md. : 1950) 2007 Feb 15;178(4):2229-40
Journal of immunology (Baltimore, Md. : 1950) 2007 Feb 15;178(4):2229-40
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Boniface K, Diveu C, Morel F, Pedretti N, Froger J, Ravon E, Garcia M, Venereau E, Preisser L, Guignouard E, Guillet G, Dagregorio G, Pène J, Moles JP, Yssel H, Chevalier S, Bernard FX, Gascan H, Lecron JC
Journal of immunology (Baltimore, Md. : 1950) 2007 Apr 1;178(7):4615-22
Journal of immunology (Baltimore, Md. : 1950) 2007 Apr 1;178(7):4615-22
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Boniface K, Diveu C, Morel F, Pedretti N, Froger J, Ravon E, Garcia M, Venereau E, Preisser L, Guignouard E, Guillet G, Dagregorio G, Pène J, Moles JP, Yssel H, Chevalier S, Bernard FX, Gascan H, Lecron JC
Journal of immunology (Baltimore, Md. : 1950) 2007 Apr 1;178(7):4615-22
Journal of immunology (Baltimore, Md. : 1950) 2007 Apr 1;178(7):4615-22
Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.
Méhul B, Bernard D, Brouard M, Delattre C, Schmidt R
Experimental dermatology 2006 Jun;15(6):469-77
Experimental dermatology 2006 Jun;15(6):469-77
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.
Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP
Cancer research 2005 Nov 15;65(22):10265-72
Cancer research 2005 Nov 15;65(22):10265-72
Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation.
Martinsson H, Yhr M, Enerbäck C
Experimental dermatology 2005 Mar;14(3):161-8
Experimental dermatology 2005 Mar;14(3):161-8
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes.
Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F
Journal of immunology (Baltimore, Md. : 1950) 2005 Mar 15;174(6):3695-702
Journal of immunology (Baltimore, Md. : 1950) 2005 Mar 15;174(6):3695-702
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes.
Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F
Journal of immunology (Baltimore, Md. : 1950) 2005 Mar 15;174(6):3695-702
Journal of immunology (Baltimore, Md. : 1950) 2005 Mar 15;174(6):3695-702
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection.
Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM
Nature immunology 2005 Jan;6(1):57-64
Nature immunology 2005 Jan;6(1):57-64
A putative role for psoriasin in breast tumor progression.
Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K
Cancer research 2005 Dec 15;65(24):11326-34
Cancer research 2005 Dec 15;65(24):11326-34
Molecular markers in ductal carcinoma in situ of the breast.
Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K
Molecular cancer research : MCR 2003 Mar;1(5):362-75
Molecular cancer research : MCR 2003 Mar;1(5):362-75
Psoriasin expression in mammary epithelial cells in vitro and in vivo.
Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K
Cancer research 2002 Jan 1;62(1):43-7
Cancer research 2002 Jan 1;62(1):43-7
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Simple Western: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Analysis using Azide Free version of NB100-56559. Image shows a specific band for Psoriasin/S100A7 in 0.05 mg/mL of MCF-7 lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Analysis using Azide Free version of NB100-56559. Psoriasin in A) MCF10A and B) MCF7 cell lysate using psoriasin antibody at 1 ug/mL.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Tissue section of human esophageal squamous cell carcinoma (SCC) using 5 ug/mL concentration of Psoriasin/S100A7 antibody (clone 47C1068). Diffused to granular cytoplasmic immunostaining was observed all over the tissue section with highest expression levels in the areas with cancer cells especially in the developing squamous keratin pearls.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Analysis of FFPE tissue section of human lymph node cancer using 5 ug/mL concentration of Psoriasin/S100A7 antibody (clone 47C1068). Very strong cytoplasmic immunopositivity of Psoriasin/S100A7 protein was observed in the cancer cells.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Staining of human skin. FFPE tissue after heat-induced antigen retrieval. Antibody concentration 10 ug/mL.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Human breast tissue stained with psoriasin antibody at 1:200 using peroxidase-conjugate and DAB chromogen. Antigen retrieval with citrate buffer, pH 6.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Activities of proinflammatory cytokines on the differentiation of Reconstituted Human Epidermis. RHE have been cultured for 10 days at the air-water interface using an appropriate differentiation medium and then with or without recombinant IL-1alpha, IL-17A, IL-22, OSM or TN alpha alone or in combination during 72 h for immunohistological analysis. RHE were fixed, embedded in paraffin and 4 um vertical sections were stained with Hematoxylin and Eosin (HE) or with anti-CK10, anti-LOR, anti-FLG, anti-IVL or anti-S100A7 mAbs. Results are from one experiment representative of two. Image collected and cropped by CiteAb from the following publication (http://dx.plos.org/10.1371/journal.pone.0101937), licensed under a CC-BY licence.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry: S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - Inhibition of KDM expression in vivo. Skin biopsies from normal control skin (Cont) or lesional psoriatic skin (Pso) were collected. Skin sections were stained with Hematoxylin and immunodetection of cytokeratin 10, loricrin, filaggrin, involucrin and S100A7 was performed. Scale bar 100 um. Results are from one experiment representative of three. Image collected and cropped by CiteAb from the following publication (http://dx.plos.org/10.1371/journal.pone.0101937), licensed under a CC-BY licence.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow (Intracellular): S100A7/Psoriasin Antibody (47C1068) [NB100-56559] - An intracellular stain was performed on Jurkat cells with S100A7/Psoriasin antibody (47C1068) NBP2-24911PE (blue) and a matched isotype control NBP2-27287PE (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 1 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to phycoerythrin.